Carson Wealth (CWM LLC)’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.19K Hold
1,398
﹤0.01% 5081
2025
Q4
$8K Hold
1,398
﹤0.01% 4674
2025
Q3
$15K Buy
+1,398
New +$12.4K ﹤0.01% 4286

Other funds holding XGN

Carson Wealth (CWM LLC)'s XGN Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Exagen (XGN) position steady in Q1 2026 at 1,398 shares worth $4.19K. The position accounts for ﹤0.01% of the portfolio, ranked #5081.

Carson Wealth (CWM LLC) first reported a position in XGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $15K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,398 shares of Exagen worth $4.19K as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Exagen share count unchanged in Q1 2026.
  • Exagen made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5081 holding.
  • Carson Wealth (CWM LLC) first reported a position in Exagen in Q3 2025 and has held it in 3 quarters since.
  • Carson Wealth (CWM LLC)'s Exagen position peaked at $15K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.